🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Aim and objectives: This trial aims to evaluate the role of adjuvant radio...
Status
Active Not Recruiting
Location
Tata Memorial Centre
Start Date
2016-06-02
Trial ID
NCT02951325
Treatments Being Tested
This phase II trial evaluates whether early switching from modified fluorou...
Status
Active Not Recruiting
Location
OHSU Knight Cancer Institute
Start Date
2021-05-27
Trial ID
NCT04539808
The purpose of this Phase II study will be to investigate the antiangiogeni...
Status
Completed
Location
Florida Cancer Specialists
Start Date
2013-01
Trial ID
NCT01749956
Treatments Being Tested
This phase II trial studies how well nab-paclitaxel and gemcitabine hydroch...
Status
Completed
Location
OHSU Knight Cancer Institute
Start Date
2016-01-21
Trial ID
NCT02427841
Patients with advanced ovarian cancer (FIGO stage III C) and highly dissemi...
Status
Completed
Location
Catholic University of the Sacred Heart
Start Date
2011-10-01
Trial ID
NCT01461850
Whole brain radiotherapy (WBRT) has long been a practical and effective the...
Status
Recruiting
Location
Chang Gung Memorial Hospital
Start Date
2013-01-18
Trial ID
NCT02504788
Treatments Being Tested
This study hypothesizes that approximately 50% of rectal cancer patients ca...
Status
Recruiting
Location
Nacional Cancer Institute
Start Date
2025-01-06
Trial ID
NCT06758830
The ACO/ARO/AIO-21 investigator-driven, open-labeled, phase I drug re-purpo...
Status
Completed
Location
University Hospital Goethe University Frankfurt
Start Date
2021-08-20
Trial ID
NCT04942626
RATIONALE: Growth factors, such as palifermin, may lessen the severity of m...
Status
Terminated
Location
Mayo Clinic Scottsdale
Start Date
2006-07
Trial ID
NCT00360971
Treatments Being Tested
This phase II trial studies how well prostate specific membrane antigen (PS...
Status
Recruiting
Location
University of Pittsburgh Cancer Institute (UPCI)
Start Date
2020-09-30
Trial ID
NCT04175431